Orchestra BioMed Gets $6.1 Million From Vivasure Sale
NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) received a $6.1 million milestone payment Sept. 14 tied to Haemonetics Corp.’s acquisition of Vivasure Medical Limited, lifting its cash …
Orchestra BioMed Gets $6.1 Million From Vivasure Sale Read More